Cardioprotection by metabolic shut-down and gradual wake-up.
about
The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinasesToll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2Myoglobin and mitochondria: a relationship bound by oxygen and nitric oxidePhysiological consequences of complex II inhibition for aging, disease, and the mKATP channelLoss of Intralipid®- but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signalingComplex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathyUnderstanding and preventing mitochondrial oxidative damageHypoxia tolerance, nitric oxide, and nitrite: lessons from extreme animalsRedox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular diseaseProtein Oxidative Modifications: Beneficial Roles in Disease and HealthMitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts.Isoflurane modulates cardiac mitochondrial bioenergetics by selectively attenuating respiratory complexesMitochondrial dysfunction and resuscitation in sepsis.Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+.Potential therapeutic benefits of strategies directed to mitochondria.A cell-based phenotypic assay to identify cardioprotective agentsIschaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.Lysine deacetylation in ischaemic preconditioning: the role of SIRT1Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols.Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis.Differential regulation of metabolism by nitric oxide and S-nitrosothiols in endothelial cells.Inorganic nitrite therapy: historical perspective and future directions.Ischemic preconditioning: the role of mitochondria and agingMitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion.Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection.Mitochondria: redox metabolism and dysfunction.What makes the mitochondria a killer? Can we condition them to be less destructive?Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms.Mitochondria as a drug target in ischemic heart disease and cardiomyopathyFatty acid nitroalkenes induce resistance to ischemic cardiac injury by modulating mitochondrial respiration at complex IITLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons.Quantitative characterization of changes in the cardiac mitochondrial proteome during anesthetic preconditioning and ischemiaComplex I and ATP synthase mediate membrane depolarization and matrix acidification by isoflurane in mitochondriaCaspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress.Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells.Optogenetic control of ROS production.Mitochondria as metabolizers and targets of nitrite.
P2860
Q21132337-AB345DDD-3639-497B-9BA4-DD43E09EFDF7Q24338906-1F799D22-CAA6-4250-AE2D-03F29B621727Q26828919-7D4D8359-DBC3-41EF-8328-408D8D331FADQ27002338-3A4FC564-551C-41FB-A1EC-1CA4B35259FEQ27314973-80AD5C15-2951-405F-8168-637B04A9F076Q27342864-E04989CC-D3B5-4CAE-BD0E-4C8185CB08EDQ28080331-CFB1D7F4-0C1E-4EDF-82B1-CEC582984CFDQ28082590-DA88B806-B20B-4479-BA25-043ABE8036E9Q28390704-BBB10C6D-009B-4B28-BA87-A0D661C280F0Q28397786-0D4FFF97-F0BD-41E1-9022-A2344D39E3B1Q30597699-29E10EAC-48D2-423F-A2F1-4F274EDE6D40Q33855763-25E690A6-A9CD-4923-99F0-21E8E4753A62Q34014042-749E699B-19C2-4DE7-A72E-EE5E35F6607CQ34085718-7159F1F1-B953-4508-965E-857982ECF0EBQ34117168-5FD8AB39-F673-4F66-A29B-118A591E10C0Q34186419-AB6C06A9-2FF0-49F6-832F-6558DD7C057AQ34447034-1CB4E1A7-3807-4EDB-94E9-05D302D45E51Q34530174-6F352DE7-682E-4EB9-948F-56C2CDC6AAF4Q34737959-36E84C26-BD4B-458C-9557-908C9D06B5BDQ34854255-1241BE88-F685-4A1E-8B86-CB9B91F56CF0Q35053534-CC540656-464C-4D7A-9067-776F648D87C5Q35101307-635F3697-31CD-4680-9A27-71961025C3F5Q35315038-BC72F28D-74B8-4809-96FB-577F94EBA4E2Q35552149-FB96C1D4-81E7-47CD-9260-B4355F41F9E1Q35631620-DD664A52-629D-4293-A0CC-B527843AB4B1Q35819387-CD84F2D7-6C08-4EE8-9CA2-6F8F897BD194Q35928926-A2644107-7A89-4A4F-B78E-240EEC0D735FQ35944831-AAA42AA6-5590-4813-8205-E394A8434440Q36099938-0E864707-3111-4F4E-B46D-5C939A04E7F4Q36268944-6644896B-B471-452C-9313-7A4155ACEA75Q36274955-D38EED57-AB3C-4E46-A198-7E8363FC107FQ36426316-AFCD39D2-FA50-4FDD-871B-A9285C0FC3A5Q36456806-0D653BF4-BA96-4D34-A264-0F68AAC7E449Q36729539-025F8585-9D92-4E6A-B27A-260AC4727DC7Q36737648-4480738F-ABC4-4F33-AF83-F0FD67305D5CQ36842276-6BC4ED4E-6EC1-42B3-86A8-33429C7E17BEQ36890691-1E80879B-906F-4D55-B220-A26BC21451BAQ37133497-4449FB18-12F6-41C6-A5A4-4AA00F30BC53Q37587840-4F21F7C0-BF50-45F0-801D-150A60428CC1Q37605280-C22BAFE9-5806-4D9E-8C1A-5E445FAB1635
P2860
Cardioprotection by metabolic shut-down and gradual wake-up.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardioprotection by metabolic shut-down and gradual wake-up.
@en
Cardioprotection by metabolic shut-down and gradual wake-up.
@nl
type
label
Cardioprotection by metabolic shut-down and gradual wake-up.
@en
Cardioprotection by metabolic shut-down and gradual wake-up.
@nl
prefLabel
Cardioprotection by metabolic shut-down and gradual wake-up.
@en
Cardioprotection by metabolic shut-down and gradual wake-up.
@nl
P2093
P2860
P1476
Cardioprotection by metabolic shut-down and gradual wake-up.
@en
P2093
Lindsay S Burwell
Paul S Brookes
Sergiy M Nadtochiy
P2860
P304
P356
10.1016/J.YJMCC.2009.02.026
P577
2009-03-10T00:00:00Z